Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.
Shirakawa T, Makiyama A, Shimokawa M, Otsuka T, Shinohara Y, Koga F, Ueda Y, Nakazawa J, Otsu S, Komori A, Arima S, Fukahori M, Taguchi H, Honda T, Shibuki T, Nio K, Ide Y, Ureshino N, Mizuta T, Mitsugi K, Akashi K, Baba E.
Shirakawa T, et al. Among authors: mizuta t.
Sci Rep. 2024 Mar 4;14(1):5311. doi: 10.1038/s41598-024-55673-7.
Sci Rep. 2024.
PMID: 38438505
Free PMC article.
No abstract available.